Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis.
Ripa M, Rodríguez-Núñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F, Morata L, De La Calle C, Del Rio A, Garcia-Vidal C, Ortega MDM, Guerrero-León MLA, Feher C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA. Ripa M, et al. Among authors: feher c. J Antimicrob Chemother. 2017 Dec 1;72(12):3443-3452. doi: 10.1093/jac/dkx315. J Antimicrob Chemother. 2017. PMID: 28961801
The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort.
Fehér C, Múñez Rubio E, Merino Amador P, Delgado-Iribarren Garcia-Campero A, Salavert M, Merino E, Maseda Garrido E, Díaz-Brito V, Álvarez MJ, Mensa J. Fehér C, et al. Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):295-303. doi: 10.1007/s10096-016-2802-x. Epub 2016 Oct 8. Eur J Clin Microbiol Infect Dis. 2017. PMID: 27718071
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis-authors' response.
Ripa M, Rodríguez-Nuñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F, Morata L, De La Calle C, Del Río A, Garcia-Vidal C, Ortega MDM, Guerrero-León MLA, Fehér C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA. Ripa M, et al. Among authors: feher c. J Antimicrob Chemother. 2018 Jun 1;73(6):1732-1733. doi: 10.1093/jac/dky063. J Antimicrob Chemother. 2018. PMID: 29506238 No abstract available.
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa.
Rodríguez-Núñez O, Ripa M, Morata L, de la Calle C, Cardozo C, Fehér C, Pellicé M, Valcárcel A, Puerta-Alcalde P, Marco F, García-Vidal C, Del Río A, Soriano A, Martínez-Martínez JA. Rodríguez-Núñez O, et al. Among authors: feher c. J Glob Antimicrob Resist. 2018 Dec;15:136-139. doi: 10.1016/j.jgar.2018.07.010. Epub 2018 Jul 20. J Glob Antimicrob Resist. 2018. PMID: 30036695
Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Puerta-Alcalde P, Cardozo C, Suárez-Lledó M, Rodríguez-Núñez O, Morata L, Fehér C, Marco F, Del Río A, Martínez JA, Mensa J, Rovira M, Esteve J, Soriano A, Garcia-Vidal C. Puerta-Alcalde P, et al. Among authors: feher c. Clin Microbiol Infect. 2019 Apr;25(4):447-453. doi: 10.1016/j.cmi.2018.07.026. Epub 2018 Aug 7. Clin Microbiol Infect. 2019. PMID: 30096417 Free article.
52 results